RecallDepth
Class III Terminated

Romidepsin Injecton, 27.5 mg/5.5 mL (5 mg/mL) Rx Only, 5.5 ml vial, Teva Pharmaceuticals USA, Inc. NDC 0703-4004-01

Company
Teva Pharmaceuticals Usa
Recall Initiated
March 4, 2021
Posted
March 24, 2021
Recall Number
D-0309-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,416 vials
Firm Location
Parsippany, NJ, United States

Reason for Recall

Failed Impurity/Degradation Specifications: Out-of-specifications results observed for impurities during stability testing.

Distribution

Distributed Nationwide in the USA.

Lot / Code Info

Lot # 31328184C, exp. date 11/2021 Lot # 31327686C, exp. date 08/2021 Lot # 31327685C, exp. date 08/2021

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class III Drug recalls